Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds expression product or fragment thereof of...
Reexamination Certificate
2006-09-12
2006-09-12
Brumback, Brenda (Department: 1647)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Binds expression product or fragment thereof of...
C424S130100, C424S139100, C424S141100, C424S178100, C424S183100, C530S387100, C530S387700, C530S387900, C530S388100, C530S388800, C530S391300, C530S391700
Reexamination Certificate
active
07105159
ABSTRACT:
This invention provides purified antibodies to the outer membrane domain of prostate-specific membrane (PSM) antigen, compositions of matter comprising PSM antigen antibodies conjugated to a radioisotope or a toxin, and a method of imaging prostate cancer by using PSM antigen antibodies.
REFERENCES:
patent: 4554101 (1985-11-01), Hopp
patent: 5162504 (1992-11-01), Horoszewicz
patent: 5538866 (1996-07-01), Israeli et al.
patent: 5672592 (1997-09-01), Jackson et al.
patent: 5773292 (1998-06-01), Bander
patent: 5795877 (1998-08-01), Jackson et al.
patent: 5804602 (1998-09-01), Slusher et al.
patent: 5863536 (1999-01-01), Jackson et al.
patent: 5880112 (1999-03-01), Jackson et al.
patent: 5902817 (1999-05-01), Jackson et al.
patent: 5935818 (1999-08-01), Israeli et al.
patent: 5939258 (1999-08-01), Croce et al.
patent: 5962521 (1999-10-01), Jackson et al.
patent: 5968915 (1999-10-01), Jackson et al.
patent: 5981209 (1999-11-01), Slusher et al.
patent: 6011021 (2000-01-01), Slusher et al.
patent: 6017903 (2000-01-01), Slusher et al.
patent: 6025344 (2000-02-01), Jackson et al.
patent: 6025345 (2000-02-01), Jackson et al.
patent: 6046180 (2000-04-01), Jackson et al.
patent: 6054444 (2000-04-01), Jackson et al.
patent: 6107090 (2000-08-01), Bander
patent: 6121252 (2000-09-01), Jackson et al.
patent: 6136311 (2000-10-01), Bander
patent: 6150508 (2000-11-01), Murphy et al.
patent: 6271245 (2001-08-01), Jackson et al.
patent: 6288046 (2001-09-01), Jackson et al.
patent: 6348464 (2002-02-01), Jackson et al.
patent: 6372726 (2002-04-01), Slusher et al.
patent: 6384022 (2002-05-01), Jackson et al.
patent: 6395718 (2002-05-01), Slusher et al.
patent: 6413948 (2002-07-01), Slusher et al.
patent: 6452044 (2002-09-01), Jackson et al.
patent: 6458775 (2002-10-01), Jackson et al.
patent: 6479471 (2002-11-01), Jackson et al.
patent: 6569432 (2003-05-01), Israeli et al.
patent: 6586623 (2003-07-01), Tsukamoto et al.
patent: 6649163 (2003-11-01), Bander
patent: 2001/0044459 (2001-11-01), Jackson et al.
patent: 2002/0013295 (2002-01-01), Slusher et al.
patent: 2002/0015704 (2002-02-01), Bander
patent: 2002/0019430 (2002-02-01), Jackson et al.
patent: 2002/0151503 (2002-10-01), Slusher et al.
patent: 2003/0007974 (2003-01-01), Nanus et al.
patent: 2003/0017965 (2003-01-01), Slusher et al.
patent: 2003/0031673 (2003-02-01), Bander
patent: 2003/0064912 (2003-04-01), Slusher et al.
patent: 2003/0083374 (2003-05-01), Jackson et al.
patent: 2003/0105088 (2003-06-01), Tsukamoto et al.
patent: 2003/0216468 (2003-11-01), Tsukamoto et al.
patent: 2004/0001846 (2004-01-01), Israeli et al.
patent: 2004/0024188 (2004-02-01), Murphy et al.
patent: 0173951 (1986-12-01), None
patent: WO 9409820 (1994-05-01), None
patent: 9626272 (1996-08-01), None
patent: WO 9735616 (1997-10-01), None
patent: WO 9947554 (1999-09-01), None
patent: 02096460 (2002-12-01), None
patent: 02098897 (2002-12-01), None
US 6,290,956, 9/2001, Bander (withdrawn)
Feng et al. Proc. Amer. Assoc. Cancer Res. 32:239 1991.
Translation of Abstract of EP 0 173 951 (Exhibit 2); 1986.
Tortora, G.J., et al., (1989)Microbiology. An Introduction, Benjamin/Cummings Publishing Co., 423-426, 471 (Exhibit 3).
Stites, D.P., et al., (1991)Basic and Clinical Immunology, Appleton & Lange, 229-251 (Exhibit 4).
Rose, N.R., et al., (1986)Manual of Clinical Laboratory Immunology, American Society for Microbiology, 89-109 (Exhibit 5).
Paul, W.E. (1989)Fundamental Immunology, Raven Press, 628-629, 647-651 (Exhibit 6).
Gately, M.K. et al., (1992) “Regulation of Human Cytololytic Lymphocyte Responses by Interleukin-12”,Cellular Immunology143:381-385 (Exhibit 7).
Rossi, M. C. & Zetter, B.R., (1992) “Selective Stimulation of Prostatic Carcinoma Cell Proliferation by Transferrin”,PNAS89:6197-6201 (Exhibit 8).
Sambrook, J. et al., (1989)Molecular Cloning, A Laboratory Manual, Cold Spring Harbor Laboratory Press, 16.1-16.81 (Exhibit 9).
Schneider, C. et al., (1984) “Primary Structure of Human Transferrin Receptor Deduced from the mRNA sequence”,Nature311:675-678 (Exhibit 10).
U.S. Appl. No. 09/357,704, filed Jul. 20, 1999, Bander.
U.S. Appl. No. 09/357,707, filed Jul. 20, 1999, Bander.
U.S. Appl. No. 09/357,708, filed Jul. 20, 1999, Bander.
U.S. Appl. No. 09/357,709, filed Jul. 20, 1999, Bander.
U.S. Appl. No. 09/357,710, filed Jul. 20, 1999, Bander.
U.S. Appl. No. 09/929,546, filed Aug. 13, 2001, Bander.
U.S. Appl. No. 09/929,665, filed Aug. 13, 2001, Bander.
U.S. Appl. No. 09/561,462, filed Apr. 28, 2000, Murphy et al.
U.S. Appl. No. 09/561,502, filed Apr. 28, 2000, Murphy et al.
U.S. Appl. No. 09/724,630, filed Nov. 28, 2000, Murphy et al.
Abdel-Nabi, H., et al. (1992) “Monoclonal Antibodies and Radioimmunoconjugates in the Diagnosis and Treatment of Prostate Cancer”, Seminars on Urology 127: 45-54 (Exhibit 5).
Axelrod, H. R., et al. (1968) “Preclinical Results and Humman Immunohitochemical Studies With 90Y-CYT-356: A New Prostate Cancer Therapeutic Agent” AUA 87th Annual Meeting, May 10-14, 1992 (Exhibit 6).
Carter, B.H. And Coffey, D.S. (1990) “The Prostate: An Increasing Medical Problem” The Prostate 16:39-48 (Exhibit 7).
Feng, Q., et al. (1991) “Purification and Biochemical Characterization of the 7E11-C5 Prostate Carcinoma-Associated Antigen”, Proceedings of the American Association for Cancer Research 32:239 (Exhibit 8).
Chang, Chawnshang, et al. (1988) “Structural Analysis of Complementary DNA and Amino Acid Sequences of Human and Rat Androgen Receptors”, Proc. Natl. Acad. Sci USA 85:7211-7215 (Exhibit 9).
Culver, K.W., et al. (1992) “In Vivo Gene Transfer with Retoviral Vector-Producer Cells for Treatment of Experimental Brain Tumors”, Science 256:1150-1552 (Exhibit 10).
Decensi, A., et al. (1991) “Phase II Study of the Pure Non-steroidal Antiandrogen Nilutamide in Prostatic Cancer”, Eur J Cancer 27:1100-1104 (Exhibit 11).
Faber, P.W., et al. (1991) “Characterization of the Human Androgen Transcription Unit” The Journal of Biological Chemistry 266:10743-10749 (Exhibit 12).
Fey, Martin F., et al. (1991) “The Polymerase Chain Reaction: A New Tool for the Detection of Minimal Residual Disease in Haematological Malignancies” Eur J Cancer 27:89-94 (Exhibit 13).
Henttu, Pirkko and Vihko, Pirkko (1989) “cDNA Coding for the Entire Human Prostate Specific Antigen Shows High Homologies to the Human Tissue Kallikrein Genes” Biochemical and Biophysical Research Communications 160:903-910 (Exhibit 14).
Horoszewicz, Julius S., et al. (1987) “Monoclonal Antibodies to a New Antigen Marker in Epithelial Prostatic Cells and Serum of Prostatic Cancer Patients” AntiCancer Research 7:927-936 (Exhibit 15).
Huber, Brian E., et al (1991) “Retroviral-mediated Gene Therapy for the Treatment of Hepatocellular Carcinoma: An Innovative Approach for Cancer Therapy” Proc. Natl. Acad. Sci. USA 88:8039-8043 (Exhibit 16).
Israeli, Ron S., et al. (1994) “Expression of the Prostate Specific Membrane Antigen” Cancer Research 54:1807-1811 (Exhibit 17).
Israeli, Ron S., et al. (1994) “Sensitive Nested Reverse Transcription Ploymerase Chain Reaction Detection of Circulating Prostatic Tumor Cells: Comparison of Prostate-specific Membrane Antigen and Prostate-specific Antigen-based Assays” Cancer Research 5:6306-6310 (Exhibit 18).
Keer, Harold N., et al. (1990) “Elevated Transferrin Receptor Content in Human Prostate Cancer Cell Lines Assessed In Vitro and In Vivo” The Journal of Urology 143:381-385 (Exhibit 19).
Lopes, A. Dwight., et al (1993) “Immonohistochemical and Pharmacokinetic Characterization of the Site-specific Immunocnjugate CYT-356 Derived from Antiprostate Monoclonal Antibody” Cancer Research 50: 6423-6429 (Exhibit 20).
Lubahn, Dennis B., et al. (1989) “Sequence of the Intron/exon junctions of the Coding Region of the Human Adrogen Receptor Gene and Identification of a Point Mutation in a family with Complete Androge
Fair William R.
Heston Warren D. W.
Israeli Ron S.
Brumback Brenda
Cooper & Dunham LLP
Gucker Stephen
Sloan-Kettering Institute for Cancer Research
White John P.
LandOfFree
Antibodies to prostate-specific membrane antigen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies to prostate-specific membrane antigen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies to prostate-specific membrane antigen will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3585209